Journal Information
Most often read
46893
Diaphragmatic dysfunctionJ. Ricoy, N. Rodríguez-Núñez, J.M. Álvarez-Dobaño, M.E. Toubes, V. Riveiro, L. Valdés
Pulmonol. 2019;25:223-35
46893
Open access
43379
New drugs and perspectives for new anti-tuberculosis regimensS. Tiberi, M. Muñoz-Torrico, R. Duarte, M. Dalcolmo, L. D’Ambrosio, G.-B. Migliori
Pulmonol. 2018;24:86-98
43379
Open access
42266
WITHDRAWN: Covid-19: Round and oval areas of ground-glass opacityW. Schmitt, E. Marchiori
42266
Open access
Available online 26 April 2020
31392
COPD exacerbations: management and hospital dischargeA.J. Reis, C. Alves, S. Furtado, J. Ferreira, M. Drummond, C. Robalo-Cordeiro
Pulmonol. 2018;24:345-50
31392
Open access
26900
Tuberculosis and gender – Factors influencing the risk of tuberculosis among men and women by age groupR. Marçôa, A.I. Ribeiro, I. Zão, R. Duarte
Pulmonol. 2018;24:199-202
26900
Open access
26675
Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysisR. Torres-Castro, L. Vasconcello-Castillo, X. Alsina-Restoy, L. Solis-Navarro, F. Burgos, H. Puppo, J. Vilaró
Pulmonol. 2021;27:328-37
26675
Open access
Open Article
25769
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effectsD. Visca, C.W.M. Ong, S. Tiberi, R. Centis, L. D’Ambrosio, B. Chen, J. Mueller, P. Mueller, R. Duarte, M. Dalcolmo, G. Sotgiu, G.B. Migliori, D. Goletti
Pulmonol. 2021;27:151-65
25769
Open access
Open Article
24219
Identification and assessment of COPD exacerbationsA.S. Oliveira, J. Munhá, A. Bugalho, M. Guimarães, G. Reis, A. Marques
Pulmonol. 2018;24:42-7
24219
Open access
22455
Tuberculosis, social determinants and co-morbidities (including HIV)R. Duarte, K. Lönnroth, C. Carvalho, F. Lima, A.C.C. Carvalho, M. Muñoz-Torrico, R. Centis
Pulmonol. 2018;24:115-9
22455
Open access
21834
COPD and Cardiovascular DiseaseS. André, B. Conde, E. Fragoso, J.P. Boléo-Tomé, V. Areias, J. Cardoso
Pulmonol. 2019;25:168-76
21834
Open access
21179
COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problemsJ.C. Winck, N. Ambrosino
Pulmonol. 2020;26:213-20
21179
Open access
19993
Medical masks and Respirators for the Protection of Healthcare Workers from SARS-CoV-2 and other virusesMariachiara Ippolito, Filippo Vitale, Giuseppe Accurso, Pasquale Iozzo, Cesare Gregoretti, Antonino Giarratano, Andrea Cortegiani
Pulmonol. 2020;26:204-12
19993
Open access
18763
The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectivesJ.L. Boechat, I. Chora, A. Morais, L. Delgado
Pulmonol. 2021;27:423-37
18763
Open access
17534
COVID-19 and asthma: To have or not to have T2 inflammation makes a difference?M. Morais-Almeida, J. Bousquet
Pulmonol. 2020;26:261-3
17534
Open access
16972
Challenges for the female health-care workers during the COVID-19 pandemic: the need for protection beyond the maskClaudia Crimi, Annalisa Carlucci
Pulmonol. 2021;27:1-3
16972
Open access
Open Article
16707
Use of Helmet CPAP in COVID-19 – A practical reviewH. Amirfarzan, M. Cereda, T.G. Gaulton, K.B. Leissner, A. Cortegiani, R. Schumann, C. Gregoretti
Pulmonol. 2021;27:413-22
16707
Open access
Open Article
16384
Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centreE. Bargagli, C. Piccioli, E. Rosi, E. Torricelli, L. Turi, E. Piccioli, M. Pistolesi, K. Ferrari, L. Voltolini
Pulmonol. 2019;25:149-53
16384
Open access
16211
Role of bronchoscopy in foreign body aspiration management in adults: A seven year retrospective studyC. Costa, S. Feijó, P. Monteiro, L. Martins, J.Rosal. Gonçalves
Pulmonol. 2018;24:50-2
16211
Open access
15821
Covid-19: Round and oval areas of ground-glass opacityW. Schmitt, E. Marchiori
Pulmonol. 2020;26:246-7
15821
Open access
15087
Cigarette smoking and COVID-19Marco Rossato, Angelo Di Vincenzo
Pulmonol. 2021;27:277-8
15087
Open access
Open Article